Neonatal mortality from respiratory distress syndrome: lessons for low-resource countries

Beena D Kamath1, Emily R Macguire, Elizabeth M McClure

  • 1Division of Neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. beena.kamath@cchmc.org

Pediatrics
|May 4, 2011
PubMed

Insights

Widespread use of oxygen and continuous positive airway pressure significantly reduced respiratory distress syndrome (RDS) mortality in high-income nations. These interventions, alongside supportive care, offer the greatest potential to decrease neonatal mortality in low-resource settings.

Area of Science:

  • Neonatal Medicine
  • Public Health
  • Medical Technology History

Background:

  • Respiratory distress syndrome (RDS) is a leading cause of newborn death globally.
  • Limited data exists on RDS-specific mortality rates in low-income countries.
  • Inconsistent application of RDS treatments across healthcare settings is a challenge.

Observation:

  • Historical analysis of RDS interventions in high-income countries over 60 years.
  • Identification of key technologies and therapies contributing to reduced mortality.
  • Focus on the sequential introduction and impact of different treatments.

Findings:

  • The most significant declines in RDS-specific mortality correlated with the widespread adoption of oxygen therapy and continuous positive airway pressure (CPAP).
  • These two interventions, when implemented broadly, demonstrated the greatest impact on survival rates.
  • The study highlights a historical trend in effective RDS management.

Implications:

  • Implementing widespread oxygen and CPAP in low-resource settings, supported by essential infrastructure and general newborn care, can substantially decrease neonatal mortality.
  • This historical perspective provides evidence-based guidance for policymakers allocating resources to improve newborn survival globally.
  • Prioritizing accessible and effective interventions like oxygen and CPAP is crucial for global neonatal health equity.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...